527 related articles for article (PubMed ID: 21623239)
21. Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer.
Nakao S; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Anticancer Res; 2019 Oct; 39(10):5725-5731. PubMed ID: 31570474
[TBL] [Abstract][Full Text] [Related]
22. Comparison of clinical characteristics and outcomes between combined pulmonary fibrosis and emphysema associated with usual interstitial pneumonia pattern and non-usual interstitial pneumonia.
Sugino K; Nakamura Y; Ito T; Isshiki T; Sakamoto S; Homma S
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):129-37. PubMed ID: 26278692
[TBL] [Abstract][Full Text] [Related]
23. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival.
Fischer A; Swigris JJ; Groshong SD; Cool CD; Sahin H; Lynch DA; Curran-Everett D; Gillis JZ; Meehan RT; Brown KK
Chest; 2008 Sep; 134(3):601-605. PubMed ID: 18403656
[TBL] [Abstract][Full Text] [Related]
24. High resolution computed tomography patterns in interstitial lung disease (ILD): prevalence and prognosis.
Almeida RF; Watte G; Marchiori E; Altmayer S; Pacini GS; Barros MC; Paza Junior A; Runin AS; Salem MCGG; Hochhegger B
J Bras Pneumol; 2020; 46(5):e20190153. PubMed ID: 32159601
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib.
Takano T; Ohe Y; Kusumoto M; Tateishi U; Yamamoto S; Nokihara H; Yamamoto N; Sekine I; Kunitoh H; Tamura T; Kodama T; Saijo N
Lung Cancer; 2004 Jul; 45(1):93-104. PubMed ID: 15196739
[TBL] [Abstract][Full Text] [Related]
26. Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy.
Sekine A; Matama G; Hagiwara E; Tabata E; Ikeda S; Oda T; Okuda R; Kitamura H; Baba T; Satoh H; Misumi T; Komatsu S; Iwasawa T; Ogura T
Thorac Cancer; 2022 Sep; 13(17):2443-2449. PubMed ID: 35840339
[TBL] [Abstract][Full Text] [Related]
27. Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer.
Ozawa Y; Akahori D; Koda K; Abe T; Hasegawa H; Matsui T; Tanahashi M; Niwa H; Yamada K; Yokomura K; Suda T
Cancer Chemother Pharmacol; 2016 May; 77(5):1031-8. PubMed ID: 27048413
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of second-line chemotherapy for patients with advanced non-small cell lung cancer complicated by interstitial lung disease.
Otsuka K; Nokihara H; Mitsuhashi A; Ozaki R; Yabuki Y; Yoneda H; Ogino H; Nishioka Y
Thorac Cancer; 2022 Nov; 13(21):2978-2984. PubMed ID: 36106507
[TBL] [Abstract][Full Text] [Related]
29. Independent review of interstitial lung disease associated with death in TRIBUTE (paclitaxel and carboplatin with or without concurrent erlotinib) in advanced non-small cell lung cancer.
Yoneda KY; Shelton DK; Beckett LA; Gandara DR
J Thorac Oncol; 2007 Jun; 2(6):537-43. PubMed ID: 17545850
[TBL] [Abstract][Full Text] [Related]
30. Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study.
Hashimoto N; Ando A; Iwano S; Sakamoto K; Okachi S; Matsuzaki A; Okada Y; Wakai K; Yokoi K; Hasegawa Y
BMC Pulm Med; 2018 Jan; 18(1):2. PubMed ID: 29304775
[TBL] [Abstract][Full Text] [Related]
31. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease.
Lee HK; Kim DS; Yoo B; Seo JB; Rho JY; Colby TV; Kitaichi M
Chest; 2005 Jun; 127(6):2019-27. PubMed ID: 15947315
[TBL] [Abstract][Full Text] [Related]
32. Anticancer drug treatment for advanced lung cancer with interstitial lung disease.
Otsubo K; Okamoto I; Hamada N; Nakanishi Y
Respir Investig; 2018 Jul; 56(4):307-311. PubMed ID: 29764748
[TBL] [Abstract][Full Text] [Related]
33. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients.
Sumikawa H; Johkoh T; Ichikado K; Taniguchi H; Kondoh Y; Fujimoto K; Tateishi U; Hiramatsu T; Inoue A; Natsag J; Ikemoto M; Mihara N; Honda O; Tomiyama N; Hamada S; Nakamura H; Müller NL
Radiology; 2006 Oct; 241(1):258-66. PubMed ID: 16908678
[TBL] [Abstract][Full Text] [Related]
34. Glasgow Prognostic Score predicts chemotherapy-triggered acute exacerbation-interstitial lung disease in patients with non-small cell lung cancer.
Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
Thorac Cancer; 2021 Mar; 12(5):667-675. PubMed ID: 33480111
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows.
Takahara Y; Tanaka T; Ishige Y; Shionoya I; Yamamura K; Sakuma T; Nishiki K; Nakase K; Nojiri M; Kato R; Shinomiya S; Fujimoto Y; Oikawa T; Mizuno S
Thorac Cancer; 2021 Oct; 12(20):2758-2766. PubMed ID: 34409749
[TBL] [Abstract][Full Text] [Related]
36. Severe interstitial lung disease associated with amrubicin treatment.
Yoh K; Kenmotsu H; Yamaguchi Y; Kubota K; Ohmatsu H; Goto K; Niho S; Ohe Y; Saijo N; Nishiwaki Y
J Thorac Oncol; 2010 Sep; 5(9):1435-8. PubMed ID: 20683210
[TBL] [Abstract][Full Text] [Related]
37. ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease.
Kobayashi H; Naito T; Omae K; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Murakami H; Endo M; Takahashi T
Lung Cancer; 2018 Jul; 121():48-53. PubMed ID: 29858026
[TBL] [Abstract][Full Text] [Related]
38. Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.
Akaike K; Saruwatari K; Okabayashi H; Hamada S; Jodai Y; Jodai T; Sakata S; Iyama S; Sato R; Iriki T; Tomita Y; Saeki S; Ichiyasu H; Fujii K
Anticancer Res; 2018 Nov; 38(11):6543-6550. PubMed ID: 30396984
[TBL] [Abstract][Full Text] [Related]
39. A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease.
Okamoto M; Fujimoto K; Sadohara J; Furuya K; Kaieda S; Miyamura T; Suematsu E; Kitasato Y; Kawayama T; Ida H; Ichiki M; Hoshino T
Respir Investig; 2016 Nov; 54(6):445-453. PubMed ID: 27886856
[TBL] [Abstract][Full Text] [Related]
40. Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study.
Araya T; Kita T; Ueda T; Terada N; Sakai T; Yamamura K; Kurokawa K; Uchida Y; Sone T; Kimura H; Kasahara K
Can Respir J; 2019; 2019():5315903. PubMed ID: 31015884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
